Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.32 is 84% above its 5-year average of -1.96, around the middle of its 5-year range (-9.47–5.73).
23.81% above its 12-month average of -0.42.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.06.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T20:58:54.655Z. Historical observations retain their original dates. Historical series through 2023-06-30.
EARNINGS PER SHARE (EPS)
-0.32
EARNINGS PER SHARE (EPS) AVG TTM
-0.42
EARNINGS PER SHARE (EPS) AVG 3Y
0.90
EARNINGS PER SHARE (EPS) AVG 5Y
-1.96
EARNINGS PER SHARE (EPS) AVG 10Y
-8.57
EARNINGS PER SHARE (EPS) AVG 15Y
-11.97
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+23.81%
CURRENT VS 3Y AVG
-135.56%
CURRENT VS 5Y AVG
+83.63%
CURRENT VS 10Y AVG
+96.27%
CURRENT VS 15Y AVG
+97.33%
CURRENT VS 20Y AVG
N/A
Talphera, Inc.
Market Cap
$57.61M
Earnings Per Share (EPS)
-0.32
TTM Avg
-0.42
3Y Avg
0.90
5Y Avg
-1.96
Market Cap
$57.76M
Earnings Per Share (EPS)
N/A
TTM Avg
-3.23
3Y Avg
-2.68
5Y Avg
-2.37
Market Cap
$58.06M
Earnings Per Share (EPS)
-2.02
TTM Avg
-7.29
3Y Avg
-26.82
5Y Avg
-38.33
Market Cap
$57.01M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.64
3Y Avg
-4.21
5Y Avg
-9.38
Market Cap
$58.29M
Earnings Per Share (EPS)
-2.39
TTM Avg
-2.92
3Y Avg
-5.17
5Y Avg
-5.77
Market Cap
$58.43M
Earnings Per Share (EPS)
N/A
TTM Avg
-19.12
3Y Avg
-29.60
5Y Avg
-38.42
Market Cap
$58.44M
Earnings Per Share (EPS)
-0.64
TTM Avg
-0.89
3Y Avg
-1.15
5Y Avg
-1.02
Market Cap
$59.18M
Earnings Per Share (EPS)
-1.64
TTM Avg
-9.73
3Y Avg
-25.86
5Y Avg
-294.77
Market Cap
$56.02M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.18
3Y Avg
-0.24
5Y Avg
-0.27
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Talphera, Inc. (TLPH) | $57.61M | -0.32 | -0.42 | 0.90 | -1.96 |
| Boundless Bio, Inc. (BOLD)vs › | $57.76M | N/A | -3.23 | -2.68 | -2.37 |
| Kalaris Therapeutics Inc (KLRS)vs › | $58.06M | -2.02 | -7.29 | -26.82 | -38.33 |
| Connect Biopharma Holdings Limited (CNTB)vs › | $57.01M | N/A | -0.64 | -4.21 | -9.38 |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.29M | -2.39 | -2.92 | -5.17 | -5.77 |
| Adicet Bio, Inc. (ACET)vs › | $58.43M | N/A | -19.12 | -29.60 | -38.42 |
| PDS Biotechnology Corporation (PDSB)vs › | $58.44M | -0.64 | -0.89 | -1.15 | -1.02 |
| Xilio Therapeutics, Inc. (XLO)vs › | $59.18M | -1.64 | -9.73 | -25.86 | -294.77 |
| OKYO Pharma Limited (OKYO)vs › | $56.02M | N/A | -0.18 | -0.24 | -0.27 |
| Aldeyra The (ALDX)vs › | $55.25M | -0.39 | -0.75 | -0.80 | -0.90 |
Trailing EPS (TTM)
$-0.32
Forward EPS (Est.)
$-0.20
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.34 |
| 2024-12-31 | -0.50 |
| 2023-12-31 | -1.29 |
| 2022-12-31 | 5.73 |
| 2021-12-31 | -5.86 |
| 2020-12-31 | -9.47 |
| 2019-12-31 | -13.45 |
| 2018-12-31 | -16.14 |
| 2017-12-31 | -21.97 |
| 2016-12-31 | -19.05 |
| 2015-12-31 | -11.93 |
| 2014-12-31 | -18.20 |
| 2013-12-31 | -11.80 |
| 2012-12-31 | -30.16 |
| 2011-12-31 | -23.18 |
| 2010-12-31 | -13.95 |
| 2009-12-31 | -19.56 |
| 2008-12-31 | -20.09 |
| 2007-12-31 | -9.36 |
